Repository logo
 

Controlling Inflammation Through DNA Damage and Repair.

Accepted version
Peer-reviewed

Type

Article

Change log

Authors

Shah, Aarti 

Abstract

Advanced atherosclerotic plaques demonstrate extensive DNA damage, seen in smooth muscle cells, endothelial cells, macrophages and in circulating cells, and in both nuclei and mitochondria.1 DNA damage includes both single- or double-stranded breaks, deleted sections of DNA, nucleotide modifications, and extrusions of DNA from the nucleus (micronuclei). Reactive oxygen species (ROS) induce a variety of DNA damage, including oxidatively modified bases, apurinic/apyrimidinic sites, and strand breaks. Guanine is the most readily oxidized base, reacting with OH to generate a reducing neutral radical that reacts with O2, and via electron transfer, forms 8-oxo-7,8-dihydroguanine (8-oxo-G).2 8-oxo-G and its products are the most abundant DNA lesions on oxidative exposure, with 1 to 2/106 residues in nuclear DNA and 1 to 3/105 residues in mitochondrial DNA (mtDNA), and up to 105 8-oxo-G lesions are formed in the cell daily.1 Advanced plaques are characterized by extensive accumulation of 8-oxo-G, seen in both macrophages and smooth muscle cells.3,4 8-oxo-G is primarily repaired by base excision repair by several enzymes, including specific 8-oxo-G DNA glycosylases I5 and II6 (OGG1/2) and the Nei-like (NEIL) glycosylases; the excised DNA is repaired by AP endonucleases before gap filling by polymerases and ligation.

Description

Keywords

DNA damage, Ediorials, atherosclerosis, microRNA, oxidative stress, reactive oxygen species, DNA Damage, DNA Repair, Humans, Inflammation, Oxidative Stress, Reactive Oxygen Species

Journal Title

Circ Res

Conference Name

Journal ISSN

0009-7330
1524-4571

Volume Title

119

Publisher

Ovid Technologies (Wolters Kluwer Health)
Sponsorship
British Heart Foundation (PG/16/11/32021)
British Heart Foundation (None)
British Heart Foundation (None)
British Heart Foundation (None)
British Heart Foundation (Grant ID: RG/13/14/30314), Cambridge NIHR Biomedical Research Centre